Susann Teneberg

Title: Susann Teneberg: Innovator in Cancer Diagnostics

Introduction

Susann Teneberg is a notable inventor based in Hindås, Sweden. She has made significant contributions to the field of cancer diagnostics through her innovative research and patented inventions. Her work focuses on oligosaccharide sequences that are specifically expressed by human tumors, providing new avenues for cancer detection and treatment.

Latest Patents

Teneberg holds a patent for "Tumor specific oligosaccharide sequences and use thereof." This invention describes oligosaccharide sequences that are specifically expressed by human tumors. The method outlined in her patent involves determining an oligosaccharide sequence that includes a tumor-specific terminal N-acetylglucosamine residue in a biological sample. The presence of this sequence serves as an indication of cancer. Additionally, her invention provides antigenic substances comprising these oligosaccharide sequences in a polyvalent form, along with diagnostic agents, pharmaceutical compositions, and cancer vaccines that utilize these sequences or substances that bind to them. The patent also relates to methods for the treatment of cancer.

Career Highlights

Throughout her career, Teneberg has worked with various companies, including Glykos Finland Oy and Nestec S.A. Her experience in these organizations has contributed to her expertise in the field of biochemistry and cancer research.

Collaborations

Some of her notable coworkers include Jari Natunen and Karl-Anders Karlsson. Their collaboration has likely enhanced the research and development of her innovative ideas.

Conclusion

Susann Teneberg's contributions to cancer diagnostics through her patented inventions highlight her role as a leading innovator in the field. Her work not only advances scientific understanding but also has the potential to improve cancer detection and treatment methods.